Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Screening for Cystic Fibrosis-Related Diabetes: Matching Pathophysiology and Addressing Current Challenges
Valérie Boudreau, Quitterie Reynaud, Catherine Lehoux Dubois, et al.
Canadian Journal of Diabetes (2016) Vol. 40, Iss. 5, pp. 466-470
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Cystic Fibrosis-Related Diabetes
Kayani Kayani, Raihan Mohammed, Hasan Mohiaddin
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 88
The trials and tribulations of determining HbA1c targets for diabetes mellitus
Klara R. Klein, John B. Buse
Nature Reviews Endocrinology (2020) Vol. 16, Iss. 12, pp. 717-730
Closed Access | Times Cited: 54
Cystic Fibrosis-Related Diabetes Screening in Adults: A Gap Analysis and Evaluation of Accuracy of Glycated Hemoglobin Levels
Julie Gilmour, Jenna Sykes, Edward Etchells, et al.
Canadian Journal of Diabetes (2018) Vol. 43, Iss. 1, pp. 13-18
Open Access | Times Cited: 36
Diabetes Risk in Childhood Cancer Survivors: A Population-Based Study
Iliana C. Lega, Jason D. Pole, Peter C. Austin, et al.
Canadian Journal of Diabetes (2018) Vol. 42, Iss. 5, pp. 533-539
Closed Access | Times Cited: 28
Renal involvement and metabolic alterations in adults patients affected by cystic fibrosis
Silvia Lai, Sandro Mazzaferro, Anna Paola Mitterhofer, et al.
Journal of Translational Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 26
Advances in cystic fibrosis-related diabetes: Current status and future directions
F. Lurquin, Martin Buysschaert, Vanessa Preumont
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 11, pp. 102899-102899
Open Access | Times Cited: 8
Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis
Anne Bonhoure, Kathryn J. Potter, Johann Colomba, et al.
Diabetologia (2021) Vol. 64, Iss. 6, pp. 1332-1341
Open Access | Times Cited: 19
Cystic Fibrosis-Related Diabetes: Clinical approach and knowledge gaps
Bernadette Prentice, Kathryn J. Potter, Adèle Coriati, et al.
Paediatric Respiratory Reviews (2022) Vol. 46, pp. 3-11
Closed Access | Times Cited: 13
The Relationship Between Continuous Glucose Monitoring and OGTT in Youth and Young Adults With Cystic Fibrosis
Christine L. Chan, Laura Pyle, Tim Vigers, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 107, Iss. 2, pp. e548-e560
Open Access | Times Cited: 17
Glycated Hemoglobin as a First-line Screening Test for Cystic Fibrosis‒Related Diabetes and Impaired Glucose Tolerance in Children With Cystic Fibrosis: A Validation Study
Florence Racine, Azadeh Shohoudi, Valérie Boudreau, et al.
Canadian Journal of Diabetes (2021) Vol. 45, Iss. 8, pp. 768-774
Closed Access | Times Cited: 13
Evolving Mechanistic Views and Emerging Therapeutic Strategies for Cystic Fibrosis–Related Diabetes
John C. Yoon
Journal of the Endocrine Society (2017) Vol. 1, Iss. 11, pp. 1386-1400
Open Access | Times Cited: 16
HOMA indices as screening tests for cystic fibrosis-related diabetes
Tom Toin, Quitterie Reynaud, Angélique Denis, et al.
Journal of Cystic Fibrosis (2021) Vol. 21, Iss. 1, pp. 123-128
Open Access | Times Cited: 12
Validation of a Stepwise Approach Using Glycated Hemoglobin Levels to Reduce the Number of Required Oral Glucose Tolerance Tests to Screen for Cystic Fibrosis–Related Diabetes in Adults
Valérie Boudreau, Quitterie Reynaud, Anne Bonhoure, et al.
Canadian Journal of Diabetes (2018) Vol. 43, Iss. 3, pp. 161-162
Closed Access | Times Cited: 14
A provider survey of cystic fibrosis related diabetes screening and management practices at North American CF centers
Rebecca Hicks, Katie Larson Ode, Tim Vigers, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 4
The use of fructosamine in cystic fibrosis-related diabetes (CFRD) screening
Grace Y. Lam, Michelle Doll-Shankaruk, Jan Dayton, et al.
Journal of Cystic Fibrosis (2017) Vol. 17, Iss. 1, pp. 121-124
Open Access | Times Cited: 12
Continuous glucose monitoring to evaluate glycaemic abnormalities in cystic fibrosis
Mariana Zorrón Mei Hsia Pu, Aline Cristina Gonçalves, Walter José Minnicucci, et al.
Archives of Disease in Childhood (2018) Vol. 103, Iss. 6, pp. 592-596
Closed Access | Times Cited: 12
Adult Care in Cystic Fibrosis
J.S. Elborn
Seminars in Respiratory and Critical Care Medicine (2019) Vol. 40, Iss. 06, pp. 857-868
Closed Access | Times Cited: 12
Canadian Cystic Fibrosis–related Diabetes Clinical Practice Survey: Analysis of Current Practices and Gaps in Clinical Care
Kathryn J. Potter, Adèle Coriati, Patrick Hicks, et al.
Canadian Journal of Diabetes (2023) Vol. 47, Iss. 3, pp. 263-271.e1
Closed Access | Times Cited: 4
Glucose tolerance in Canadian and French cystic fibrosis adult patients
Quitterie Reynaud, Valérie Boudreau, Sandrine Touzet, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 10
Impact of 1h oral glucose tolerance test on the clinical status of adult cystic fibrosis patients over a 4-year period
Valérie Boudreau, Quitterie Reynaud, Angélique Denis, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0246897-e0246897
Open Access | Times Cited: 9
Combined Indeterminate and Impaired Glucose Tolerance Is a Novel Group at High Risk of Cystic Fibrosis-Related Diabetes
Kathryn J. Potter, Quitterie Reynaud, Valérie Boudreau, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 10, pp. e3901-e3910
Open Access | Times Cited: 9
Sensitivity and specificity of cystic fibrosis-related diabetes screening methods: which test should be the reference method?
Valérie Boudreau, Catherine Lehoux Dubois, Katherine Desjardins, et al.
Journal of Pediatric Endocrinology and Metabolism (2017) Vol. 30, Iss. 8
Open Access | Times Cited: 9
Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis
Johann Colomba, Silvia R. Netedu, C. Lehoux-Dubois, et al.
PLoS ONE (2019) Vol. 14, Iss. 7, pp. e0219855-e0219855
Open Access | Times Cited: 9
The effect of probiotic administration on metabolomics and glucose metabolism in CF patients
Michal Gur, Nehama Zuckerman‐Levin, Kamal Masarweh, et al.
Pediatric Pulmonology (2022) Vol. 57, Iss. 10, pp. 2335-2343
Open Access | Times Cited: 6
Retinopathy and microalbuminuria are common microvascular complications in cystic fibrosis-related diabetes
Punith Kempegowda, H. Sunsoa, Joht Singh Chandan, et al.
Therapeutic Advances in Endocrinology and Metabolism (2020) Vol. 11
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top